Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $212.8300 (-0.6%) ($212.7950 - $215.2100) on Tue. Oct. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.76% (three month average) | RSI | 44 | Latest Price | $212.8300(-0.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -0.4% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IGOV(32%) IWF(23%) SMH(22%) QQQ(21%) VUG(21%) | Factors Impacting SGEN price | SGEN will decline at least -0.38% in a week (0% probabilities). EDOC(-42%) UNG(-34%) XME(-32%) REMX(-30%) XOP(-23%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.38% (StdDev 0.76%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $214.87 | 5 Day Moving Average | $214.79(-0.91%) | 10 Day Moving Average | $215.34(-1.17%) | 20 Day Moving Average | $214.87(-0.95%) | To recent high | -2% | To recent low | 11% | Market Cap | $37.004b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |